Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GUIDED THERAPEUTICS INC (GTHP)
|
Add to portfolio |
|
|
|
| Price: |
$0.68
| | Metrics |
| OS: |
51.3
|
M
| |
|
|
| Market cap: |
$34.6
|
M
| |
|
|
|
Net cash:
|
$1.36
|
M
| |
$0.03
|
per share
|
|
EV:
|
$33.3
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 0.1 | 0.1 | 0.0 | 0.1 | 0.2 | 0.6 | 0.0 | 0.1 |
| Revenue growth | -20.6% | 183.3% | -36.8% | -76.6% | -59.7% | 1340.5% | -35.4% | -92.1% |
| Cost of goods sold | 0.1 | 0.0 | 0.1 | 0.1 | 0.5 | 0.5 | 0.5 | 0.9 |
| Gross profit | 0.0 | 0.1 | 0.0 | 0.0 | -0.3 | 0.1 | -0.5 | -0.8 |
| Gross margin | 24.7% | 59.8% | -94.4% | -56.1% | -117.2% | 18.5% | -1178.6% | -1270.8% |
| Sales and marketing | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.4 | 0.7 | 1.2 |
| Research and development | 0.1 | 0.1 | 0.1 | 0.2 | 0.3 | 0.7 | 1.5 | 2.8 |
| General and administrative | 2.2 | 0.9 | 0.7 | 1.1 | 2.3 | 2.8 | 4.1 | 4.6 |
| EBITA | -2.4 | -1.0 | -0.8 | -1.5 | -3.1 | -3.8 | -6.2 | -8.7 |
| EBITA margin | -2906.2% | -931.4% | -2347.2% | -2715.8% | -1279.1% | -631.4% | -14826.2% | -13336.9% |
| Amortization of intangibles | 0.0 | 0.1 | 0.1 | | | | | |
| EBIT | -2.4 | -1.1 | -0.9 | -1.5 | -3.1 | -3.8 | -6.2 | -8.7 |
| EBIT margin | -2916.0% | -1031.4% | -2602.8% | -2715.8% | -1279.1% | -631.4% | -14826.2% | -13336.9% |
| Pre-tax income | -2.1 | -0.3 | -1.9 | 1.0 | -10.7 | -4.0 | -6.9 | -9.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -2.4 | -0.4 | -1.9 | 0.9 | -11.0 | -5.0 | -9.5 | -10.0 |
| Net margin | -3001.2% | -393.1% | -5336.1% | 1578.9% | -4497.5% | -825.6% | -22626.2% | -15438.5% |
| |
| Diluted EPS | ($0.18) | ($37.24) | ($0.58) | $0.01 | ($997,636.36) | ($24.61) | ($4,751,500.00) | ($13.02) |
| Shares outstanding (diluted) | 13.4 | 0.0 | 3.3 | 65.2 | 0.0 | 0.2 | 0.0 | 0.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|